Table 2 Direct medical costs of bladder cancer in terms of diagnostic and treatment procedures in Iran (2018)
From: Direct and indirect medical costs of bladder cancer in Iran
Stage | Cost ($) | |||||||
|---|---|---|---|---|---|---|---|---|
White-light-guided TURBT (including patology, visit, drug, …) | Intravesical mitomycin C | Urologist visit | BCG therapy | Imaging & Lab services | Radical cystectomy | Chemotherapy& radiotherapy | Total | |
Ta low | 2,556,120 | 154,564 | 134,128 | 0.00 | 1,027,200 | 0.00 | 0.00 | 3,872,013 |
Ta High | 1,278,060 | 0.00 | 44,106 | 1,090,376.86 | 422,090 | 0.00 | 0.00 | 2,834,633 |
T1 | 1,825,800 | 0.00 | 57,185 | 1,479,149.19 | 549,481 | 0.00 | 0.00 | 3,911,615 |
CIS | 456,450 | 0.00 | 27,290 | 722,494.61 | 263,628 | 0.00 | 0.00 | 1,469,863 |
NMIBC recurrent | 2,246,918 | 119,690 | 72,007 | 1,117,765.53 | 618,192 | 0.00 | 0.00 | 4,174,573 |
T2–T3 | 418,141 | 0.00 | 88,783 | 0.00 | 1,144,568 | 5,728,305 | 1,125,251 | 8,505,048 |
Metastases | 105,407 | 0.00 | 59,837 | 0.00 | 820,590 | 0.00 | 2,904,332 | 3,890,166 |
Total | 8,886,896 | 274,254 | 483,337 | 4,409,786.19 | 4,845,749 | 5,728,305 | 4,029,583 | 28,657,910 |
Percent of total | 31.01 | 0.96 | 1.69 | 15.39 | 16.91 | 19.99 | 14.06 | 100.00 |